Hereditary Malignant Neoplasm — Trials

Hereditary Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

78 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 25
Recruiting: 14
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06065059	Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors	terminated	Phase 1 / Phase 2	7	Tango Therapeutics, Inc.INDUSTRY	1	Aug 13, 2024	clinicaltrials
NCT00727532	Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer	terminated	N/A	9	Northwestern UniversityOTHER	1	May 3, 2019	clinicaltrials